Trial NCT03220867

View at ClinicalTrials.gov 
Org. Study IDs: CR108341
Secondary IDs: R064766SCH1013

Last trial update was posted on 2018-02-28

MeSH Interventions

Risperidone

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

CFDA announced Xi'An Risperdal as reference drug, no need for this BE trial from both scientific and ethical perspective.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID